RIBOMIC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90 JPY | 0.00% |
|
-8.16% | -16.67% |
Valuation
| Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9,569 | 5,513 | 10,159 | 5,997 | 6,710 | 3,318 |
| Enterprise Value (EV) 1 | 8,157 | 3,513 | 4,321 | 1,296 | 2,385 | -81.19 |
| P/E ratio | -11.4 x | -5.86 x | -7.88 x | -3.5 x | -3.54 x | -3.24 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1,367 x | 45.6 x | 112 x | 75 x | 103 x | - |
| EV / Revenue | 1,165 x | 29 x | 47.5 x | 16.2 x | 36.7 x | - |
| EV / EBITDA | -9.04 x | -3.92 x | -3.56 x | -0.75 x | -1.34 x | 0.07 x |
| EV / FCF | -13.3 x | -5.14 x | -5.69 x | -1.38 x | -1.97 x | 0.13 x |
| FCF Yield | -7.52% | -19.5% | -17.6% | -72.4% | -50.8% | 793% |
| Price to Book | 6.46 x | 2.43 x | 1.69 x | 1.28 x | 1.53 x | 0.99 x |
| Nbr of stocks (in thousands) | 14,390 | 17,556 | 27,909 | 28,559 | 35,693 | 35,675 |
| Reference price 2 | 665.0 | 314.0 | 364.0 | 210.0 | 188.0 | 93.00 |
| Announcement Date | 6/28/19 | 7/31/20 | 6/30/21 | 6/29/22 | 6/28/23 | 6/26/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | 7 | 121 | 91 | 80 | 65 | - |
| EBITDA 1 | -902 | -897 | -1,214 | -1,734 | -1,787 | -1,106 |
| EBIT 1 | -929 | -914 | -1,240 | -1,749 | -1,787 | -1,116 |
| Operating Margin | -13,271.43% | -755.37% | -1,362.64% | -2,186.25% | -2,749.23% | - |
| Earnings before Tax (EBT) 1 | -835 | -854 | -1,186 | -1,683 | -1,652 | -1,023 |
| Net income 1 | -836 | -855 | -1,187 | -1,684 | -1,653 | -1,024 |
| Net margin | -11,942.86% | -706.61% | -1,304.4% | -2,105% | -2,543.08% | - |
| EPS 2 | -58.17 | -53.62 | -46.16 | -59.92 | -53.14 | -28.69 |
| Free Cash Flow 1 | -613.6 | -683.2 | -759 | -939.1 | -1,211 | -643.5 |
| FCF margin | -8,766.07% | -564.67% | -834.07% | -1,173.91% | -1,862.88% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/28/19 | 7/31/20 | 6/30/21 | 6/29/22 | 6/28/23 | 6/26/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Marzo | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | 4 | 5 | 2 | 2 | 3 | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -563 | -778 | -348 | -632 | -927 | -585 | -338 | -581 | -248 |
| Operating Margin | -14,075% | -15,560% | -17,400% | -31,600% | -30,900% | - | - | - | - |
| Earnings before Tax (EBT) 1 | -587 | -767 | -346 | -612 | -878 | -597 | -334 | -554 | -247 |
| Net income 1 | -588 | -767 | -347 | -613 | -878 | -598 | -334 | -554 | -248 |
| Net margin | -14,700% | -15,340% | -17,350% | -30,650% | -29,266.67% | - | - | - | - |
| EPS 2 | -25.01 | -27.51 | -12.35 | -21.47 | -30.77 | -19.10 | -9.390 | -15.55 | -6.950 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/12/20 | 11/9/21 | 2/14/22 | 8/9/22 | 11/11/22 | 2/10/23 | 8/10/23 | 11/13/23 | 2/13/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 1,412 | 2,000 | 5,838 | 4,701 | 4,325 | 3,399 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -614 | -683 | -759 | -939 | -1,211 | -644 |
| ROE (net income / shareholders' equity) | -45.1% | -46.7% | -29% | -31.5% | -36.4% | -26.3% |
| ROA (Net income/ Total Assets) | -23.7% | -23.6% | -18.5% | -19.7% | -23.4% | -17.2% |
| Assets 1 | 3,524 | 3,621 | 6,424 | 8,529 | 7,057 | 5,968 |
| Book Value Per Share 2 | 103.0 | 129.0 | 215.0 | 164.0 | 123.0 | 94.20 |
| Cash Flow per Share 2 | 98.20 | 95.00 | 120.0 | 102.0 | 79.20 | 58.30 |
| Capex 1 | 16 | 46 | 1 | 10 | 23 | 22 |
| Capex / Sales | 228.57% | 38.02% | 1.1% | 12.5% | 35.38% | - |
| Announcement Date | 6/28/19 | 7/31/20 | 6/30/21 | 6/29/22 | 6/28/23 | 6/26/24 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 20.8M | |
| +20.12% | 126B | |
| +25.25% | 119B | |
| +25.56% | 27.95B | |
| -19.51% | 20.5B | |
| -14.36% | 17.12B | |
| -15.63% | 16.1B | |
| -46.67% | 14.97B | |
| +11.89% | 14.84B | |
| +57.74% | 14.38B |
- Stock Market
- Equities
- 4591 Stock
- Financials Ribomic Inc.
